If TFC can offload Santalis for a big cash profit....depends on outcome of multiple trials. The data in the JPM Healthcare conference presentation released to the ASX suggests a sale of Santalis could be worth $US300-=$US500m (80c-$1.40 per TFC share) based on other comparable transactions.
If TFC can offload Santalis for a big cash profit....depends on...
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)